KRAS and cancer: In addition, the authors demonstrated, for the first time, that both genetic signatures derived by Loboda and Singh were able to identify a dependency on K-RAS in patient-derived xenograft (PDX) models of PDAC, which is a more reliable, patient-like experimental system, demonstrating the predictive capability of these two gene signatures identified by in-vitro cancer models.